NVCI will be a breeding ground for the latest discoveries in cancer treatments, screening methods, technologies and prevention with the goal of becoming a “Comprehensive Cancer Center” by 2010. When asked about the role of research at the institute, Heather responded, “Research is the foundation upon which we build every dimension of the institute: education and support. It’s not just about treatment, but everything that we do will involve the pursuit of research and further understanding, not only about the disease, but also to help people cope with the disease.”

In order for NVCI to achieve its aim of conducting cuttingedge research, the Murrens have been very careful and diligent in their efforts to attract top scientists and doctors. Already on board are former Director of the University of Chicago Cancer Research Center Nicholas J. Vogelzang, M.D. as its Director and Member of the National Academy of Sciences of the U.S.A. David C. Ward, Ph.D. as its deputy director. Jim’s brother Dr. John R. Murren, Chief of the Yale Medical Oncology Clinic and associate professor of medicine, Yale University School of Medicine, has also provided his assistance and has served as the institute’s acting Director of Clinical Research.